➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,501,818

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,501,818 protect, and when does it expire?

Patent 8,501,818 protects VALCHLOR and is included in one NDA.

This patent has forty patent family members in twenty countries.

Summary for Patent: 8,501,818
Title:Stabilized compositions of alkylating agents and methods of using same
Abstract: Provided are stable compositions comprising alkylating agents, including nitrogen mustards, that are suitable for topical use, and methods for treating skin disorders comprising topically administering the compositions.
Inventor(s): Alonso; Robert (Rye, NH), Stogniew; Martin (Blue Bell, PA), Crooks; Peter A. (Nicholasville, KY), Pimley; Mark A. (Westchester, PA), Worthen; David R. (Wakefield, RI)
Assignee: Ceptaris Therapeutics, Inc. (Malvern, PA)
Application Number:12/687,605
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,501,818

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn VALCHLOR mechlorethamine hydrochloride GEL;TOPICAL 202317-001 Aug 23, 2013 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,501,818

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006223076 ⤷  Try it Free
Canada 2600468 ⤷  Try it Free
China 101175735 ⤷  Try it Free
China 102036557 ⤷  Try it Free
China 107149591 ⤷  Try it Free
Cyprus 1113305 ⤷  Try it Free
Denmark 1858864 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.